140 related articles for article (PubMed ID: 18704303)
21. In vitro and in vivo anti-hepatitis B virus activities of the lignan niranthin isolated from Phyllanthus niruri L.
Liu S; Wei W; Shi K; Cao X; Zhou M; Liu Z
J Ethnopharmacol; 2014 Sep; 155(2):1061-7. PubMed ID: 25009077
[TBL] [Abstract][Full Text] [Related]
22. [Inhibiting effects of root of Mallotus apelta on duck hepatitis B virus].
Xu S; Lü ZP; Cai HB; Zhang XG; Liu Q; Tan Y
Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):285-8. PubMed ID: 16696917
[TBL] [Abstract][Full Text] [Related]
23. Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model.
Le Guerhier F; Thermet A; Guerret S; Chevallier M; Jamard C; Gibbs CS; Trépo C; Cova L; Zoulim F
J Hepatol; 2003 Mar; 38(3):328-34. PubMed ID: 12586299
[TBL] [Abstract][Full Text] [Related]
24. The SATE pronucleotide approach applied to acyclovir: part II. Effects of bis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo.
Hantz O; Périgaud C; Borel C; Jamard C; Zoulim F; Trépo C; Imbach JL; Gosselin G
Antiviral Res; 1999 Jan; 40(3):179-87. PubMed ID: 10027652
[TBL] [Abstract][Full Text] [Related]
25. Viral load in 1-day-old ducklings acutely infected with duck hepatitis B virus by different doses and routes of inoculation.
Chen ZY; Cheng AC; Wang MS; Xu DW; Jia R; Guo YF; Zeng W
Avian Pathol; 2009 Apr; 38(2):129-34. PubMed ID: 19322711
[TBL] [Abstract][Full Text] [Related]
26. [Antisense oligodeoxynucleotide targeted at the pre-s region of DHBV could inhibit virus replication in vivo].
He L; Wu X; Chen C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):1-4. PubMed ID: 12515159
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo.
Hafkemeyer P; Keppler-Hafkemeyer A; al Haya MA; von Janta-Lipinski M; Matthes E; Lehmann C; Offensperger WB; Offensperger S; Gerok W; Blum HE
Antimicrob Agents Chemother; 1996 Mar; 40(3):792-4. PubMed ID: 8851615
[TBL] [Abstract][Full Text] [Related]
28. Effect of Oenanthe javanica flavone on human and duck hepatitis B virus infection.
Wang WN; Yang XB; Liu HZ; Huang ZM; Wu GX
Acta Pharmacol Sin; 2005 May; 26(5):587-92. PubMed ID: 15842778
[TBL] [Abstract][Full Text] [Related]
29. Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.
Foster WK; Miller DS; Scougall CA; Kotlarski I; Colonno RJ; Jilbert AR
J Virol; 2005 May; 79(9):5819-32. PubMed ID: 15827196
[TBL] [Abstract][Full Text] [Related]
30. [The inhibitory effect of compound liuyuexue on DHBV DNA].
Zhang SJ; Lin J; Jiang WZ; Huang CX; Huamg RB
Zhong Yao Cai; 2007 Feb; 30(2):191-3. PubMed ID: 17571772
[TBL] [Abstract][Full Text] [Related]
31. Postexposure treatment of experimental DHBV infection: a new therapeutic strategy.
Freiman JS; Murray SM; Vickery K; Lim D; Cossart YE
J Med Virol; 1990 Apr; 30(4):272-6. PubMed ID: 2142501
[TBL] [Abstract][Full Text] [Related]
32. Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection.
Foster WK; Miller DS; Marion PL; Colonno RJ; Kotlarski I; Jilbert AR
Antimicrob Agents Chemother; 2003 Aug; 47(8):2624-35. PubMed ID: 12878529
[TBL] [Abstract][Full Text] [Related]
33. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis.
Reaiche GY; Le Mire MF; Mason WS; Jilbert AR
Virology; 2010 Oct; 406(2):286-92. PubMed ID: 20705309
[TBL] [Abstract][Full Text] [Related]
34. Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo.
Noordeen F; Vaillant A; Jilbert AR
Antimicrob Agents Chemother; 2013 Nov; 57(11):5299-306. PubMed ID: 23939904
[TBL] [Abstract][Full Text] [Related]
35. Duck hepatitis B virus model for screening of antiviral agents from medicinal herbs.
Mi Z; Chen H; Zhang X; Shao X; Li Z; Wu X
Chin Med J (Engl); 1995 Sep; 108(9):660-4. PubMed ID: 8575230
[TBL] [Abstract][Full Text] [Related]
36. Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model.
Seignères B; Martin P; Werle B; Schorr O; Jamard C; Rimsky L; Trépo C; Zoulim F
Antimicrob Agents Chemother; 2003 Jun; 47(6):1842-52. PubMed ID: 12760857
[TBL] [Abstract][Full Text] [Related]
37. Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies.
Zoulim F; Berthillon P; Guerhier FL; Seigneres B; Germon S; Pichoud C; Cheng YC; Trepo C
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S460-3. PubMed ID: 12534778
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replication.
Aguesse-Germon S; Liu SH; Chevallier M; Pichoud C; Jamard C; Borel C; Chu CK; Trépo C; Cheng YC; Zoulim F
Antimicrob Agents Chemother; 1998 Feb; 42(2):369-76. PubMed ID: 9527788
[TBL] [Abstract][Full Text] [Related]
39. Rise in gamma interferon expression during resolution of duck hepatitis B virus infection.
Narayan R; Buronfosse T; Schultz U; Chevallier-Gueyron P; Guerret S; Chevallier M; Saade F; Ndeboko B; Trepo C; Zoulim F; Cova L
J Gen Virol; 2006 Nov; 87(Pt 11):3225-3232. PubMed ID: 17030856
[TBL] [Abstract][Full Text] [Related]
40. Transmission of duck hepatitis B virus from Chinese carrier ducks to Japanese ducklings: a study of viral DNA in serum and tissue.
Omata M; Yokosuka O; Imazeki F; Matsuyama Y; Uchiumi K; Ito Y; Mori J; Okuda K
Hepatology; 1984; 4(4):603-7. PubMed ID: 6745848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
